Mode
Text Size
Log in / Sign up

Hepatic insulin resistance linked to greater central obesity in Korean adults with type 2 diabetesWhat does liver insulin resistance reveal about type 2 diabetes?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note association between hepatic insulin resistance and central obesity in Korean T2D patients; cross-sectional data.

A cross-sectional cohort study within the Korean National Diabetes Program analyzed 2,475 Korean adults with type 2 diabetes mellitus. Participants were categorized into tertiles based on their Hepatic Insulin Resistance Index (HIRI), calculated from oral glucose tolerance tests, and metabolic profiles were compared between groups.

The main finding was significantly greater central obesity in the high-HIRI group, with a mean waist circumference of 90.92 cm compared to 85.52 cm in the lower group (p < 0.001). The study also examined other secondary outcomes including glycemic parameters, lipid profiles, liver function markers, dietary intake, and metabolic syndrome components, but specific results for these were not reported in the provided data. Safety and tolerability data were not reported.

Key limitations stem from the study's observational, cross-sectional design, which can only show association, not establish causation between hepatic insulin resistance and metabolic traits. The population was exclusively Korean, limiting generalizability to other ethnic groups. Funding sources and conflicts of interest were not reported. For clinical practice, this evidence suggests hepatic insulin resistance may be a marker associated with adverse metabolic phenotypes, specifically central obesity, in this patient group, but it does not inform on clinical outcomes or therapeutic interventions.

When you have type 2 diabetes, the problem isn't just about your pancreas—it's also about how your liver responds to insulin. A new study looked at this liver-specific resistance in over 2,400 Korean adults already living with the condition. The researchers grouped people based on a measure called the Hepatic Insulin Resistance Index, which estimates how poorly the liver is responding to insulin signals.

The most striking finding was about body shape. People in the group with the highest liver insulin resistance had an average waist circumference of about 91 centimeters, compared to about 86 centimeters in the group with the lowest resistance. That's a noticeable difference you can see and measure, and it points toward more central obesity—the kind of belly fat that's closely tied to heart disease and other metabolic risks.

It's important to understand what this study can and cannot tell us. Because it looked at people at a single point in time, we can only say these two things—liver insulin resistance and a larger waist—are strongly connected. We don't know if one causes the other, or if something else is driving both. The study also focused on a Korean population, so the specific findings might not translate directly to other ethnic groups. This research gives doctors one more clue to consider in the complex puzzle of type 2 diabetes management.

What this means for you:
In type 2 diabetes, high liver insulin resistance is linked to a larger waistline.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
AimsTo characterize the metabolic profiles associated with the Hepatic Insulin Resistance Index (HIRI), in Korean patients with type 2 diabetes mellitus.MethodsThis cross-sectional study analyzed 2,475 Korean adults with type 2 diabetes from the Korean National Diabetes Program cohort. Participants were categorized into HIRI tertiles based on oral glucose tolerance tests. We examined associations between HIRI and anthropometric measures, glycemic parameters, lipid profiles, liver function markers, and dietary intake. Logistic regression assessed the risk of dyslipidemia and metabolic syndrome components, adjusting for relevant confounders.ResultsHigh-HIRI participants demonstrated greater central obesity (waist circumference 90.92 vs. 85.52 cm, p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.